Topiramate
Product Images NDC 68258-7156

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68258-7156). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-7156-xx (Ndc 68258 7156 Xx Caraco)

Label for Topiramate 100 mg tablets from Dispensing Solutions, Inc. The label shows the product name, strength, dosage form, and NDC 68258-7156. It indicates each film-coated tablet contains 100 mg Topiramate USP. Warnings include fetal harm risk during pregnancy and instructions to dispense with medication guide. The label includes bulk source data from Caraco Pharmaceutical, dispensing instructions, and a barcode.*

FDA Label Image

Topiramate-fig01 (Topiramate Fig01)

A line graph showing the cumulative rates of time to first seizure for two groups: Topiramate 50 mg/day and Topiramate 400 mg/day. The x-axis represents time in days (0 to 500), and the y-axis shows the cumulative rate to first seizure (0 to 0.50). The graph compares seizure occurrence over time between the two dosage groups with a p-value of 0.0002.*

FDA Label Image

Topiramate-structure (Topiramate Structure)

Chemical structure diagram displaying the molecular formula of the active ingredient in TOPIRAMATE, as supplied by Dispensing Solutions, Inc. The structure illustrates the atomic configuration and bonds within the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.